1. Home
  2. LHX vs ALC Comparison

LHX vs ALC Comparison

Compare LHX & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L3Harris Technologies Inc.

LHX

L3Harris Technologies Inc.

HOLD

Current Price

$282.16

Market Cap

53.5B

Sector

Industrials

ML Signal

HOLD

Logo Alcon Inc.

ALC

Alcon Inc.

HOLD

Current Price

$79.03

Market Cap

38.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LHX
ALC
Founded
1895
1945
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5B
38.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LHX
ALC
Price
$282.16
$79.03
Analyst Decision
Buy
Buy
Analyst Count
17
12
Target Price
$297.56
$88.71
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
01-29-2026
11-11-2025
Dividend Yield
1.67%
0.27%
EPS Growth
46.76
N/A
EPS
9.29
2.10
Revenue
$21,740,000,000.00
$10,185,000,000.00
Revenue This Year
$4.06
$5.79
Revenue Next Year
$6.00
$7.36
P/E Ratio
$30.89
$36.85
Revenue Growth
2.83
4.34
52 Week Low
$193.09
$71.55
52 Week High
$308.12
$99.20

Technical Indicators

Market Signals
Indicator
LHX
ALC
Relative Strength Index (RSI) 48.28 53.82
Support Level $276.11 $78.25
Resistance Level $292.89 $79.78
Average True Range (ATR) 5.76 1.09
MACD 1.24 -0.08
Stochastic Oscillator 48.29 24.65

Price Performance

Historical Comparison
LHX
ALC

About LHX L3Harris Technologies Inc.

In addition to its legacy software-defined radio franchise, L3Harris Technologies has through a series of acquisitions established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It also adapts civilian aircraft for military use and provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: